- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01135940
The Use of Dermabond Versus Standard Staple for Wound Closure in Children With Neuromuscular Scoliosis Undergoing Spinal Deformity Correction Surgery
May 30, 2016 updated by: University of British Columbia
The Use of Dermabond vs. Standard Staple for Wound Closure in Children With Neuromuscular Scoliosis Undergoing Spinal Deformity Correction Surgery: A Phase II Study
This is a prospective, Phase II (hypothesis generating) randomized pilot study investigating the efficacy of using Dermabond as a method of final wound closure as compared to the standard staple method in children with Neuromuscular Scoliosis undergoing spinal deformity correction surgery.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
- To explore whether there is a difference in the incidence of wound infection in the Dermabond group vs. the skin staple group as measured by microbiological culture four days post-operatively. Wound infection is defined as prolonged sterile discharge (>4 days), positive wound cultures, or cellulitis four or more days post-operatively.
- To explore whether there is a difference in the cosmetic result of the wound closure as measured by the Hollander wound evaluation scale. Our hypothesis is that the Dermabond group will have a better cosmetic result. Secondary outcome
- To explore whether there is a difference in the time for final wound closure. Our hypothesis is that the Dermabond group will have a shorter time for final wound closure. Secondary outcome
- To explore whether there is a difference in mean caregiver/parental satisfaction scores as measured by a visual analog scale. Our hypothesis is that parental satisfaction will be higher in the Dermabond group. Secondary outcome
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6H 3V4
- Recruiting
- British Columbia Children's Hospital Department of Orthopaedics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 15 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- male or female 19 years or younger
- neuromuscular scoliosis
- undergoing posterior spinal instrumentation and fusion (one stage)
Exclusion Criteria:
- other non-neuromuscular causes of scoliosis
- previous history of spinal surgery
- previous incision over the operative site
- history of keloid formation
- allergy to superglue
- use of anticoagulation therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
2-octylcyanoacrylate (Dermabond) closure
|
Standard procedure for closure of adipose/ subcutaneous layers.
The subcuticular layer will be closed with a continuous 2-0 vicryl suture which will then be followed by Dermabond closure.
|
|
Active Comparator: 2
Standard staple closure
|
Standard procedure for closure of adipose/ subcutaneous layers followed by staple closure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in the incidence of wound infection in Dermabond group versus the skin staple group
Time Frame: 12 weeks after surgery
|
To explore whether there is a difference in the incidence of wound infection in Dermabond group versus the skin staple group as measured by microbiological culture taken 4 days post-operatively.
Wound infection is defined as prolonged sterile discharge , positive wound cultures, or cellulitis four or more days post-operatively.
|
12 weeks after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in the cosmetic result of the wound closure as measured by the Hollander wound evaluation scale
Time Frame: 12 weeks after surgery
|
To explore whether there is a difference in the cosmetic result of the wound closure as measured by the Hollander wound evaluation scale.
Our hypothesis is that the Dermabond group will have a better cosmetic result.
|
12 weeks after surgery
|
|
Difference in the time for final wound closure
Time Frame: Day of surgery
|
To explore whether there is a difference in the time for final wound closure.
Our hypothesis is that the Dermabond group will have a shorter time for final wound closure.
|
Day of surgery
|
|
Difference in mean caregiver/parental satisfaction scores as measured by a visual analog scale
Time Frame: 12 weeks after surgery
|
To explore whether there is a difference in mean caregiver/parental satisfaction scores as measured by a visual analog scale.
Our hypothesis is that parental satisfaction will be higher in the Dermabond group.
|
12 weeks after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Firoz Miyanji, MD, FRCSC, University of British Columbia
- Study Director: Christopher W. Reilly, MD, FRCSC, University of British Columbia
- Study Director: Kishore Mulpuri, MBBS, MS, University of British Columbia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2010
Primary Completion (Anticipated)
June 1, 2016
Study Completion (Anticipated)
June 1, 2016
Study Registration Dates
First Submitted
June 1, 2010
First Submitted That Met QC Criteria
June 2, 2010
First Posted (Estimate)
June 3, 2010
Study Record Updates
Last Update Posted (Estimate)
June 1, 2016
Last Update Submitted That Met QC Criteria
May 30, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H10-00179
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wounds
-
Centre Hospitalier Universitaire de NīmesCompleted
-
National Center for Gastroentestinal and Liver...CompletedNeedlestick Injuries
-
Solventum US LLC3MWithdrawn
-
University of WashingtonU.S. Department of Justice; Arnold Ventures; City of SeattleCompleted
-
The First Affiliated Hospital of Xinxiang Medical...Recruiting
-
Hospital Universiti Sains MalaysiaActive, not recruiting
-
Ohio State UniversityCompleted
-
SerenaGroup, Inc.MDM Wound Ventures, LLCCompletedChronic Wounds | Acute WoundsUnited States
-
University of PittsburghThe Pittsburgh Foundation; Hillman Foundation; RK Mellon FoundationCompletedSkin Injury Due to Violence | Gunshot Wound, ContactUnited States
-
University of Mississippi Medical CenterNational Institute on Minority Health and Health Disparities (NIMHD); National...Not yet recruiting
Clinical Trials on 2-octylcyanoacrylate (Dermabond) closure
-
Singapore General HospitalTerminated
-
The University of Texas Health Science Center,...Completed
-
Azienda Ospedaliero-Universitaria di ModenaCompletedGoiter | Thyroid Neoplasms | Parathyroid PathologiesItaly
-
University of California, DavisCompletedWound Closure Techniques
-
University of California, DavisCompletedUse of 2-octylcyanoacrylate (Dermabond) Versus 5-0 Fast Absorbing Gut During Cutaneous Wound ClosureWound Closure Techniques
-
Duke UniversityCompletedPort-A-Cath Placement | OctylcyanoacrylateUnited States
-
NYU Langone HealthCompletedArthropathy | Joint DiseaseUnited States
-
Centre Hospitalier Universitaire de NiceAssistance Publique Hopitaux De Marseille; Fondation Lenval; Centre Hospitalier...Completed
-
University of California, DavisCompletedScarringUnited States
-
Johnson & Johnson Medical, ChinaThe First Affiliated Hospital with Nanjing Medical University; Chinese PLA... and other collaboratorsCompleted